These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations]. Birjmohun RS; van der Steeg WA; Stroes ES; Kastelein JJ Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2245-50. PubMed ID: 17076358 [TBL] [Abstract][Full Text] [Related]
11. The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque development. Chapman MJ Curr Med Res Opin; 2005; 21 Suppl 6():S17-22. PubMed ID: 16138937 [TBL] [Abstract][Full Text] [Related]
13. Controversies on HDL: should it be a target biomarker in patients with lipid disorders? Nicholls SJ; Andrews J; Duong M Curr Vasc Pharmacol; 2014; 12(4):649-52. PubMed ID: 23627977 [TBL] [Abstract][Full Text] [Related]
14. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
15. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. Boden WE; Pearson TA Am J Cardiol; 2000 Mar; 85(5):645-50, A10. PubMed ID: 11078282 [TBL] [Abstract][Full Text] [Related]
16. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy. Rosenson RS Am Heart J; 2006 Mar; 151(3):556-63. PubMed ID: 16504615 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of low HDL-cholesterol levels in the reduction of cardiovascular risk]. Stokić E; Marinkov J Med Pregl; 2007; 60(3-4):145-50. PubMed ID: 17853726 [TBL] [Abstract][Full Text] [Related]
18. Beyond LDL-C--the importance of raising HDL-C. Wierzbicki AS; Mikhailidis DP Curr Med Res Opin; 2002; 18(1):36-44. PubMed ID: 11999145 [TBL] [Abstract][Full Text] [Related]
19. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events. Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546 [TBL] [Abstract][Full Text] [Related]
20. Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression. Negi S; Ballantyne CM J Clin Lipidol; 2010; 4(5):365-70. PubMed ID: 21122680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]